KPIs & Operating Metrics(New)
Growth Metrics

Teva Pharmaceutical Industries (TEVA) Profit After Tax Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT Growth (3y) (Qtr)
1 Haleon 111.53 Bn 109.67 Bn - -
2 Teva Pharmaceutical Industries 39.57 Bn 35.83 Bn 1.97 Bn 51.23%
3 Zoetis 33.84 Bn 31.90 Bn 1.62 Bn 2.88%
4 United Therapeutics 24.62 Bn 22.47 Bn 648.10 Mn 4.50%
5 Aurora Cannabis 17.89 Bn 17.81 Bn 33.43 Mn 69.03%
6 Neurocrine Biosciences 15.75 Bn 14.43 Bn 800.70 Mn 66.11%
7 Regencell Bioscience Holdings 13.55 Bn 13.55 Bn - -
8 Elanco Animal Health 10.61 Bn 10.18 Bn 785.00 Mn -17.90%
9 HUTCHMED (China) 10.36 Bn 9.02 Bn - -
10 Alkermes 6.14 Bn 5.63 Bn -116.06 Mn 33.65%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 51.23%
Dec 31, 2025 33.14%
Sep 30, 2025 92.18%
Jun 30, 2025 44.51%
Mar 31, 2025 30.55%
Dec 31, 2024 -12.92%
Sep 30, 2024 -51.78%
Jun 30, 2024 -83.93%
Mar 31, 2024 -95.23%
Dec 31, 2023 41.71%
Sep 30, 2023 26.33%
Jun 30, 2023 -101.89%
Mar 31, 2023 -78.28%
Dec 31, 2022 -170.41%
Sep 30, 2022 30.03%
Jun 30, 2022 26.11%
Mar 31, 2022 -114.10%
Dec 31, 2021 59.55%
Sep 30, 2021 51.57%
Jun 30, 2021 46.99%
Mar 31, 2021 -59.20%
Dec 31, 2020 26.29%
Sep 30, 2020 -108.89%
Jun 30, 2020 26.48%
Mar 31, 2020 -52.53%
Dec 31, 2019 27.59%
Sep 30, 2019 -40.08%
Jun 30, 2019 -25.99%
Mar 31, 2019 -29.13%
Dec 31, 2018 -98.28%
Sep 30, 2018 -54.64%
Jun 30, 2018 -32.51%
Mar 31, 2018 36.69%
Dec 31, 2017 -165.05%
Sep 30, 2017 -10.92%
Jun 30, 2017 -115.54%
Mar 31, 2017 -4.48%
Dec 31, 2016 -66.11%
Sep 30, 2016 -16.57%
Jun 30, 2016 7,996.25%
Mar 31, 2016 0.37%
Dec 31, 2015 21.16%
Sep 30, 2015 50.09%
Jun 30, 2015 -14.39%
Mar 31, 2015 -19.62%
Dec 31, 2014 11.18%
Sep 30, 2014 -2.04%
Jun 30, 2014 8.70%
Mar 31, 2014 -1.10%
Dec 31, 2013 -21.29%
Sep 30, 2013 -12.45%
Jun 30, 2013 -36.98%
Mar 31, 2013 -4.29%
Dec 31, 2012 -9.68%
Sep 30, 2012 -28.65%
Jun 30, 2012 17.99%
Mar 31, 2012 23.76%